LYEL
Price
$9.41
Change
+$0.26 (+2.84%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
138.23M
29 days until earnings call
PGEN
Price
$1.71
Change
+$0.12 (+7.55%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
501.81M
33 days until earnings call
Interact to see
Advertisement

LYEL vs PGEN

Header iconLYEL vs PGEN Comparison
Open Charts LYEL vs PGENBanner chart's image
Lyell Immunopharma
Price$9.41
Change+$0.26 (+2.84%)
Volume$1.19K
Capitalization138.23M
Precigen
Price$1.71
Change+$0.12 (+7.55%)
Volume$99.87K
Capitalization501.81M
LYEL vs PGEN Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. PGEN commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a StrongBuy and PGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (LYEL: $9.34 vs. PGEN: $1.70)
Brand notoriety: LYEL and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 26% vs. PGEN: 95%
Market capitalization -- LYEL: $138.23M vs. PGEN: $501.81M
LYEL [@Biotechnology] is valued at $138.23M. PGEN’s [@Biotechnology] market capitalization is $501.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, PGEN is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 4 TA indicator(s) are bullish while PGEN’s TA Score has 6 bullish TA indicator(s).

  • LYEL’s TA Score: 4 bullish, 5 bearish.
  • PGEN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а -0.95% price change this week, while PGEN (@Biotechnology) price change was +17.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

LYEL is expected to report earnings on Aug 06, 2025.

PGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($502M) has a higher market cap than LYEL($138M). PGEN YTD gains are higher at: 51.786 vs. LYEL (-28.516). PGEN has higher annual earnings (EBITDA): -154.85M vs. LYEL (-204.02M). LYEL has more cash in the bank: 301M vs. PGEN (80.2M). PGEN has less debt than LYEL: PGEN (5.42M) vs LYEL (48.9M). PGEN has higher revenues than LYEL: PGEN (4.2M) vs LYEL (65K).
LYELPGENLYEL / PGEN
Capitalization138M502M27%
EBITDA-204.02M-154.85M132%
Gain YTD-28.51651.786-55%
P/E RatioN/AN/A-
Revenue65K4.2M2%
Total Cash301M80.2M375%
Total Debt48.9M5.42M903%
FUNDAMENTALS RATINGS
PGEN: Fundamental Ratings
PGEN
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELPGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTILX28.960.01
+0.03%
Glenmede Disciplined USGrEqPtf InstlShrs
PARWX55.68N/A
N/A
Parnassus Value Equity Investor
NBMOX48.00N/A
N/A
Neuberger Berman Small Cap Growth Tr
LFGIX40.04N/A
N/A
Lord Abbett Focused Growth I
WWMCX11.59N/A
N/A
Westwood Quality Midcap Institutional

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-5.57%
VCYT - LYEL
46%
Loosely correlated
-4.25%
ZNTL - LYEL
42%
Loosely correlated
-4.03%
TYRA - LYEL
41%
Loosely correlated
-3.90%
CRBU - LYEL
40%
Loosely correlated
+1.46%
BEAM - LYEL
39%
Loosely correlated
-4.15%
More